Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.
- Anophthalmia with pulmonary hypoplasia
- Fanconi Anemia, Complementation Group D1
- Fanconi Anemia, Complementation Group N
Age: 18 years - 66+
Gender: All